Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination.
about
Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipientsCorrelation between rubella antibody levels and cytokine measures of cell-mediated immunityPredominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccineesSNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccineGM-CSF production allows the identification of immunoprevalent antigens recognized by human CD4+ T cells following smallpox vaccination.Genome-wide genetic associations with IFNγ response to smallpox vaccineOptimizing high dimensional gene expression studies for immune response following smallpox vaccination using Taqman® low density immune arraysHuman leukocyte antigen genotypes in the genetic control of adaptive immune responses to smallpox vaccine.Correlations between vaccinia-specific immune responses within a cohort of armed forces members.Effects of vitamin A and D receptor gene polymorphisms/haplotypes on immune responses to measles vaccine.Independence of measles-specific humoral and cellular immune responses to vaccinationResponse surface methodology to determine optimal measles-specific cytokine responses in human peripheral blood mononuclear cells.Impact of cytokine and cytokine receptor gene polymorphisms on cellular immunity after smallpox vaccinationInfluence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccinationGenetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine.Impaired innate, humoral, and cellular immunity despite a take in smallpox vaccine recipients.
P2860
Q28943252-A95B837B-9AC9-497A-8934-135B08EFB142Q33701522-19977C03-155C-41D4-8545-D8C21985FFABQ33706043-FAA7BF34-250C-4C45-A8B1-DE530A729AF6Q33824586-F3C351B0-19D6-401A-8C20-81A185DB9C34Q34023265-E4831CA9-CBBC-4358-9A4F-CD78E34611D1Q34221936-78A61E26-FD13-48CC-A9CE-2E2FF29820A3Q34634341-45AC5AFF-9589-494F-94E4-04C8E9E025D4Q34988328-9B087278-ED17-4DE5-9E9E-65527758343BQ35608112-9FD7A186-B0A3-44B5-8518-D841093C78EBQ35613190-82DC262A-1012-41A3-A64F-9F1A0AC8C717Q35918575-C618FD97-9515-402C-9015-F582291B2136Q36101692-80B6C654-C191-43BD-B306-384E3FF37E95Q36295858-4E990104-F76E-40BA-8780-8BFEDAA8FAE5Q37219591-C8CE20ED-EFC6-4D4D-849A-78731882AEC0Q37616442-B13469F1-6569-4115-B01F-C5D37ECBA6A8Q40675201-1057C490-B42B-4AB3-8971-E6CDB310F6A1
P2860
Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Response surface methodology t ...... ls after smallpox vaccination.
@ast
Response surface methodology t ...... ls after smallpox vaccination.
@en
type
label
Response surface methodology t ...... ls after smallpox vaccination.
@ast
Response surface methodology t ...... ls after smallpox vaccination.
@en
prefLabel
Response surface methodology t ...... ls after smallpox vaccination.
@ast
Response surface methodology t ...... ls after smallpox vaccination.
@en
P2093
P2860
P50
P1476
Response surface methodology t ...... ls after smallpox vaccination.
@en
P2093
Jenna E Ryan
Neelam Dhiman
V Shane Pankratz
P2860
P304
P356
10.1016/J.JIM.2008.11.001
P577
2008-11-25T00:00:00Z